Literature DB >> 52613

Influence of molecular structure on the tolerogenicity of bacterial dextrans. II. The alpha1--3-linked epitope of dextran B1355.

J G Howard, B M Courtenay.   

Abstract

Dextran B1355 is a branched glucose polymer containing 57 per cent alpha1--6, 35 per cent alpha1--3 and 8 per cent alpha1--2/1--4 linkages. Direct PFC responses to B1355 can be measured with sheep RBC sensitized with its O-stearoyl or palmitoyl derivative, and, as shown by inhibition analysis, are specific for an eptiope which is dependent on alpha1--3 linkages. B1355 is a potent immunogen in BALB/c mice producing peak PFC levels which approach 10(6) per spleen following an optimal dose of 1 mg. By contrast, the alpha-1--3-linked epitope of B1355 is feebly tolerogenic, for even 10 mg still induces a strong initial response. Mice given 1--10 mg sustain PFC levels 1--2 log10 above background for several months, but do not respond further to restimulation. Full recovery is attained by their spleen cells within 1 week of transfer into irradiated recipients. Deeper tolerance to this epitope was attained in vivo only when these larger doses of B1355 were injected during cyclophosphamide suppression. Two exceptions to this weak tolerogenicty were found. First, BALB/c spleen cells developed durable partial alpha1--3 tolerance following 2-hour incubation with B1355 in vitro. Second, CBA mice were fully tolerized by doses of 1 mg upwards. It is argued from these and other data in the accompanying papers that the relative resistance of BALB/c mice to induction of alpha1--3 tolerance is explicable neither as part of a more general phenomenon based on macrophage activity nor as due to an inadequate epitope density. A possible explanation based on features of the genetically determined high alpha1--3 responsiveness of BALB/c B cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52613      PMCID: PMC1446048     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Studies on immunological paralysis. X. Cellular characteristics of the induction and loss of tolerance to levan (Polyfructose).

Authors:  J J Miranda; H Zola; J G Howard
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

2.  Studies on immunological paralysis. IV. The relative contributions of continuous antibody neutralization and central inhibition to paralysis with type 3 pneumococcal polysaccharide.

Authors:  J G Howard; G H Christie; B M Courtenay
Journal:  Proc R Soc Lond B Biol Sci       Date:  1971-09-28

3.  Studies on immunological paralysis. VII. Rapid reversal of Felton's paralysis as evidence for 'tolerant' cells.

Authors:  J G Howard; G H Christie; B M Courtenay
Journal:  Proc R Soc Lond B Biol Sci       Date:  1972-03-14

4.  Studies on the induction of immunologic unresponsiveness. 3. Antigen form and mouse strain variation.

Authors:  E S Golub; W O Weigle
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

5.  The kinetics of in vivo tolerance introduction in mice.

Authors:  S Das; S Leskowitz
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

6.  Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharide.

Authors:  I Kotlarski; B M Courtenay; J G Howard
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

7.  Induction of B cell tolerance to polysaccharides by exhaustive immunization and during immunosuppression with cyclophosphamide.

Authors:  J G Howard; B M Courtenay
Journal:  Eur J Immunol       Date:  1974-09       Impact factor: 5.532

Review 8.  Immunological tolerance.

Authors:  J G Howard; N A Mitchison
Journal:  Prog Allergy       Date:  1975

9.  Influence of molecular structure on the tolerogenicity of bacterial dextrans. I. The alpha1--6-linked epitope of dextran B512.

Authors:  J G Howard; G Vicari; B M Courtenay
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

10.  Studies on immunological paralysis. IX. The immunogenicity and tolerogenicity of levan (polyfructose) in mice.

Authors:  J J Miranda
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

View more
  11 in total

1.  Genes on different chromosomes influence the antibody response to bacterial antigens.

Authors:  P J Baker; D W Bailey; M B Fauntleroy; P W Stashak; G Caldes; B Prescott
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Antigen-specific drug-targeting used to manipulate an immune response in vivo.

Authors:  M M Abu-hadid; R B Bankert; G L Mayers
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Influence of multiple genes on the magnitude of the antibody response to bacterial polysaccharide antigens.

Authors:  P J Baker; J A Rudbach; B Prescott; G Caldes; C Evans; P W Stashak
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

4.  The immune response against two epitopes on the same thymus-independent polysaccharide carrier. II. Enhanced anti-hapten responses by injection of the unconjugated carrier.

Authors:  C Fernandez; G Möller
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

5.  The mitogenic, immunogenic and tolerogenic properties of dextrans and levans. Lack of correlation according to differences of molecular structure and size.

Authors:  C Moreno; C Hale; L Ivanyi
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

6.  Influence of molecular structure of the tolerogenicity of bacterial dextrans. III. Dissociation between tolerance and immunity to the alpha1--6- and alpha1--3-linked epitopes of dextran B1355.

Authors:  J G Howard; B M Courtenay; G Vicari
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

7.  Influence of reticuloendothelial blockade on the induction of tolerance and immunity by polysaccharides.

Authors:  G Chaouat; J G Howard
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

8.  Influence of molecular structure on the tolerogenicity of bacterial dextrans. I. The alpha1--6-linked epitope of dextran B512.

Authors:  J G Howard; G Vicari; B M Courtenay
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

9.  Induction and persistence of B-cell tolerance to the thymus-dependent component of the alpha(1 leads to 6) glucosyl determinant of dextran. Recovery induced by treatment with dextranase in vivo.

Authors:  C Moreno; C Hale; R Hewett; J Esdaile
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

10.  Influence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid.

Authors:  P R Beining; G M Flannery; B Prescott; P J Baker
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.